VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 114 filers reported holding VERASTEM INC in Q3 2018. The put-call ratio across all filers is 1.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $23,000 | -28.1% | 20,750 | -10.8% | 0.03% | +40.9% |
| Q1 2022 | $32,000 | -54.3% | 23,250 | -4.1% | 0.02% | +10.0% |
| Q3 2021 | $70,000 | -20.5% | 24,250 | -4.0% | 0.02% | -44.4% |
| Q2 2021 | $88,000 | +29.4% | 25,250 | 0.0% | 0.04% | +71.4% |
| Q1 2021 | $68,000 | +28.3% | 25,250 | 0.0% | 0.02% | -8.7% |
| Q4 2020 | $53,000 | +43.2% | 25,250 | -13.7% | 0.02% | +35.3% |
| Q3 2020 | $37,000 | -26.0% | 29,250 | 0.0% | 0.02% | -19.0% |
| Q2 2020 | $50,000 | -35.1% | 29,250 | 0.0% | 0.02% | -38.2% |
| Q1 2020 | $77,000 | +97.4% | 29,250 | 0.0% | 0.03% | +142.9% |
| Q4 2019 | $39,000 | +178.6% | 29,250 | +125.0% | 0.01% | +133.3% |
| Q3 2019 | $14,000 | -68.2% | 13,000 | -55.6% | 0.01% | -70.0% |
| Q2 2019 | $44,000 | -53.2% | 29,250 | 0.0% | 0.02% | -56.5% |
| Q4 2018 | $94,000 | -34.7% | 29,250 | +30.0% | 0.05% | -40.3% |
| Q3 2018 | $144,000 | – | 22,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,018,433 | $6,217,000 | 2.19% |
| Altium Capital Management LP | 2,253,000 | $6,939,000 | 1.82% |
| BVF INC/IL | 14,977,258 | $46,130,000 | 1.80% |
| MPM BioImpact LLC | 2,824,857 | $8,701,000 | 1.35% |
| Opaleye Management Inc. | 2,325,000 | $7,161,000 | 1.34% |
| Tibra Equities Europe Ltd | 73,700 | $227,000 | 0.35% |
| Baker Brothers Advisors | 21,491,630 | $66,194,000 | 0.29% |
| Telemetry Investments, L.L.C. | 65,000 | $200,000 | 0.27% |
| Ikarian Capital, LLC | 1,227,371 | $3,780,000 | 0.27% |
| Parkman Healthcare Partners LLC | 175,797 | $541,000 | 0.14% |